发布求助
文献互助 智能选刊 最新文献

校正：在美国，抗cd38单克隆抗体联合硼替佐米、来那度胺和地塞米松一线治疗新诊断的不适合移植的多发性骨髓瘤患者的成本

IF 2.3 Q2 ECONOMICS
Journal of Health Economics and Outcomes Research Pub Date : 2025-08-12 eCollection Date: 2025-01-01 DOI:10.36469/001c.143106
Niodita Gupta-Werner, Vipin Khare, Brian Macomson, Rohan Medhekar
{"title":"校正：在美国，抗cd38单克隆抗体联合硼替佐米、来那度胺和地塞米松一线治疗新诊断的不适合移植的多发性骨髓瘤患者的成本","authors":"Niodita Gupta-Werner, Vipin Khare, Brian Macomson, Rohan Medhekar","doi":"10.36469/001c.143106","DOIUrl":null,"url":null,"abstract":"<p><p>[This corrects the article DOI: 10.36469/001c.141714.].</p>","PeriodicalId":16012,"journal":{"name":"Journal of Health Economics and Outcomes Research","volume":"12 2","pages":"62-66"},"PeriodicalIF":2.3000,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12352406/pdf/","citationCount":"0","resultStr":"{\"title\":\"Correction: Cost of Anti-CD38 Monoclonal Antibodies in Combination With Bortezomib, Lenalidomide and Dexamethasone for the Frontline Treatment of Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma in the US.\",\"authors\":\"Niodita Gupta-Werner, Vipin Khare, Brian Macomson, Rohan Medhekar\",\"doi\":\"10.36469/001c.143106\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>[This corrects the article DOI: 10.36469/001c.141714.].</p>\",\"PeriodicalId\":16012,\"journal\":{\"name\":\"Journal of Health Economics and Outcomes Research\",\"volume\":\"12 2\",\"pages\":\"62-66\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2025-08-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12352406/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Health Economics and Outcomes Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36469/001c.143106\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"ECONOMICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Health Economics and Outcomes Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36469/001c.143106","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ECONOMICS","Score":null,"Total":0}
引用次数: 0

摘要

[这更正了文章DOI: 10.36469/ 001c141714 .]。
本文章由计算机程序翻译，如有差异，请以英文原文为准。
分享
查看原文 本刊更多论文
Correction: Cost of Anti-CD38 Monoclonal Antibodies in Combination With Bortezomib, Lenalidomide and Dexamethasone for the Frontline Treatment of Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma in the US.

[This corrects the article DOI: 10.36469/001c.141714.].

求助全文
通过发布文献求助，成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Health Economics and Outcomes Research
Journal of Health Economics and Outcomes Research Medicine-Health Policy
CiteScore
3.00
自引率
0.00%
发文量
55
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信